Titration of a SHIV1157ipd3N4 Stock by Intravenous Inoculation of Chinese-Origin Rhesus Macaques
CSTR:
Author:
Affiliation:

1. Key Laboratory of Human Disease Comparative Medicine,Ministry of Health; Institute of Medical Laboratory Animal Science,Chinese Academy of Medical Sciences; Key Laboratory of Human Disease Animal Models,State Administration of Traditional Chinese Medicine ,Beijing 100021,China; 2. AIDS Institute,Li Ka Shing Faculty of Medicine,The University of Hong Kong,Hong Kong 999077,China

Clc Number:

Fund Project:

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • |
  • Materials
  • |
  • Comments
    Abstract:

    Objective To determine the viral concentration of SHIV1157ipd3N4 to infect Chinese-origin rhesus macaques intravenously, and to clarify the viral replication and immunological impairment in the monkeys after SHIV1157ipd3N4 inoculation. Methods 10 Chinese-origin rhesus macaques were used in this study. Firstly,all the monkeys were screened by serological test to ensure that they were free of SIV,SRV,and STLV. Then they were infected with 1 mL of 10-fold serial dilution of SHIV1157ipd3N4 separately. Finally to make blood routine examination and measure the viral loads of the monkeys by real-time RT-PCR. Results More than 5 TCID50 /mL of SHIV1157ipd3N4 can infect the Chinese-origin rhesus macaques i. v. successfully. Conclusions Our findings of this study provide a firm basis for establishing a SHIV1157ipd3N4 infection model of Chinese rhesus macaques intravenously. This model would be very useful for HIV-1 subtype C vaccine and pathogenesis studies.

    Reference
    Related
    Cited by
Get Citation
Related Videos

Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:October 08,2010
  • Revised:
  • Adopted:
  • Online: November 18,2025
  • Published:
Article QR Code